Use of Polyamidoamine Dendrimers in Brain Diseases
AbstractPolyamidoamine (PAMAM) dendrimers are one of the smallest and most precise nanomolecules available today, which have promising applications for the treatment of brain diseases. Each aspect of the dendrimer (core, size or generation, size of cavities, and surface functional groups) can be precisely modulated to yield a variety of nanocarriers for delivery of drugs and genes to brain cells in vitro or in vivo. Two of the most important criteria to consider when using PAMAM dendrimers for neuroscience applications is their safety profile and their potential to be prepared in a reproducible manner. Based on these criteria, features of PAMAM dendrimers are described to help the neuroscience researcher to judiciously choose the right type of dendrimer and the appropriate method for loading the drug to form a safe and effective delivery system to the brain. View Full-Text
Share & Cite This Article
Florendo, M.; Figacz, A.; Srinageshwar, B.; Sharma, A.; Swanson, D.; Dunbar, G.L.; Rossignol, J. Use of Polyamidoamine Dendrimers in Brain Diseases. Molecules 2018, 23, 2238.
Florendo M, Figacz A, Srinageshwar B, Sharma A, Swanson D, Dunbar GL, Rossignol J. Use of Polyamidoamine Dendrimers in Brain Diseases. Molecules. 2018; 23(9):2238.Chicago/Turabian Style
Florendo, Maria; Figacz, Alexander; Srinageshwar, Bhairavi; Sharma, Ajit; Swanson, Douglas; Dunbar, Gary L.; Rossignol, Julien. 2018. "Use of Polyamidoamine Dendrimers in Brain Diseases." Molecules 23, no. 9: 2238.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.